Dr. Sameh Aziz, MD
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 532
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
VA license 0101236292 · GA license 055086 -
Pulmonary Disease Physician
GA license 055086 · VA license 0101236292 -
Sleep Medicine (Internal Medicine) Physician
GA license 055086 · VA license 0101236292
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Carilion Medical Center Roanoke, VA
- Carilion New River Valley Medical Center Christiansburg, VA
- Carilion Franklin Memorial Hospital Rocky Mount, VA
- Carilion Stonewall Jackson Hospital Lexington, VA
Medical groups
- Carilion Medical Center (977 clinicians)
- Carilion Rockbridge Community Hospital (107 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 532
- Services billed
- 1,147
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 139 | 105 |
| Test to examine how well the lungs exchange gases | 115 | 114 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 108 | 107 |
| Established patient office or other outpatient visit, 20-29 minutes | 99 | 94 |
| Test to determine lung volumes using sensors | 89 | 89 |
| Critical care, first 30-74 minutes | 70 | 36 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 62 | 62 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 55 | 52 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 54 | 27 |
| Sleep study in sleep lab (6 years or older) | 48 | 45 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Orenitram Er (treprostinil diolamine) | 120 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Roanoke, VA | 93 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Roanoke, VA | 67 |
| Furosemide Other prescribers in Roanoke, VA | 67 |
| Budesonide-Formoterol Fumarate (budesonide/formoterol fumarate) Other prescribers in Roanoke, VA | 50 |
| Azithromycin Other prescribers in Roanoke, VA | 45 |
| Tyvaso Dpi (treprostinil) | 42 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Roanoke, VA | 41 |
| Omeprazole Other prescribers in Roanoke, VA | 39 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Roanoke, VA | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $121 in total to this clinician.
| Actelion Pharmaceuticals US, Inc. | $99.95 |
|---|---|
| United Therapeutics Corporation | $20.78 |
| Education | $99.95 |
|---|---|
| Food and Beverage | $20.78 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. May 6, 2025 | Education OPSUMIT; UPTRAVI · Cardiology · in-kind | $99.95 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $30,179 in research payments for these studies, mostly to the institutions running them.
- A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
United Therapeutics Corporation · Completed · NCT03626688
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.